TOP >
News Release
> list in 2010
- 2010.12.21
- Daiichi Sankyo Announces First European Approval for Sevikar HCT(R), a New Three-in-one Combination Product for the Treatment of High Blood Pressure*
- 2010.12.15
-
Daiichi Sankyo Submits Application for Additional Indication of Rifadin(R) Capsules for Nontuberculous Mycobacterial Disease
- 2010.12.13
-
Luitpold Pharmaceuticals, Inc. Acquires ROXRO PHARMA, Inc., a U.S. Company Developing Acute Pain Products
- 2010.12.08
- EDOXABAN DEMONSTRATES SUPERIOR EFFICACY COMPARED WITH ENOXAPARIN SODIUM IN PREVENTING VTE AFTER TOTAL HIP REPLACEMENT
- 2010.12.02
- DAIICHI SANKYO COMPLETES ENROLLMENT OF THE EDOXABAN GLOBAL PHASE 3 ENGAGE AF-TIMI 48 STUDY IN PATIENTS WITH ATRIAL FIBRILLATION
- 2010.11.30
- Joint Venture Company between Daiichi Sankyo and The Kitasato Institute to be Established and Begin Operations on April 1, 2011
- 2010.10.29
- AstraZeneca and Daiichi Sankyo Announce Co-Promotion Agreement for Esomeprazole Proton Pump Inhibitor in Japan
- 2010.10.29
- Differences Between Consolidated Forecasts and Results for Six Months Ended September 30, 2010 and Revisions to Consolidated Earnings Forecasts for Fiscal Year Ending March 31, 2011
- 2010.10.27
-
Daiichi Sankyo receives approval in Japan to manufacture and market Cravit(R) intravenous injections
- 2010.10.05
-
Daiichi Sankyo to Launch Percutaneous Analgesic and Anti-Inflammatory Drug Loxonin(R) Gel 1% in Japan
- 2010.09.30
- Daiichi Sankyo Espha Begins Operations in Japan to Sell Generics and Long-listed, Off-patent Pharmaceuticals with Proven Market Presence
- 2010.09.10
-
Daiichi Sankyo Receives Approval to Manufacture and Market Inavir(R) Influenza Antiviral Inhalant for Treatment in Japan
- 2010.09.10
- APPELLATE COURT AFFIRMS U.S. DISTRICT COURT DECISION IN FAVOR OF DAIICHI SANKYO PATENT FOR BENICAR(R), BENICAR HCT(R), and AZOR(R)
- 2010.08.27
- Notice of Daiichi Sankyo Organizational Restructuring to be Effective October 1, 2010
- 2010.08.25
- Daiichi Sankyo Files for Approval to Manufacture and Market AMG 162 (Denosumab) in Japan
- 2010.08.03
- ARQULE AND DAIICHI SANKYO MOVE FORWARD WITH PHASE 3 CLINICAL TRIAL PLAN FOR ARQ 197 IN NON-SMALL CELL LUNG CANCER
- 2010.07.30
-
Announcement Regarding the Establishment of a Joint Venture Company between Daiichi Sankyo and The Kitasato Institute
- 2010.07.30
- Daiichi Sankyo to Issue Stock Options (Stock Acquisition Rights) as Remuneration
- 2010.07.27
- FDA APPROVES TRIBENZOR™, A NEW THREE-IN-ONE COMBINATION PRODUCT FOR THE TREATMENT OF HIGH BLOOD PRESSURE
- 2010.07.21
- Daiichi Sankyo to Leverage Ranbaxy's Network to Market Its Innovative Antibiotic Tavanic® (Levofloxacin) in Romania and South Africa
- 2010.07.12
- EDOXABAN DEMONSTRATES SUPERIOR EFFICACY COMPARED WITH ENOXAPARIN SODIUM IN PREVENTING VTE AFTER TOTAL KNEE REPLACEMENT
- 2010.07.02
- Daiichi Sankyo and Ranbaxy to Integrate New Drug Research and Development System
- 2010.06.14
- The Japan Research Foundation for Clinical Pharmacology, A Daiichi Sankyo Foundation, has awarded Third Annual Clinical Pharmacology Research Award
- 2010.06.07
- ARQULE AND DAIICHI SANKYO PRESENT FINAL PHASE 2 RESULTS FOR ARQ 197 C-MET INHIBITOR IN NON-SMALL CELL LUNG CANCER AT ASCO
- 2010.04.06
- DAIICHI SANKYO SUBMITS FIRST NEW DRUG APPLICATION FOR ORAL FACTOR Xa INHIBITOR, EDOXABAN
- 2010.03.12
- Daiichi Sankyo Announces Second Mid-term Business Management Plan (FY 2010-2012)
- 2010.03.05
- Daiichi Sankyo to join the National Cherry Blossom Festival in Washington D.C. to celebrate the 100-year anniversary of the gift of cherry blossom trees from Japan
- 2010.02.26
- Daiichi Sankyo Group to Expand its Business Scope in Japan through Establishment of Daiichi Sankyo Espha Co., Ltd.
- 2010.02.15
- FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16(1)
- 2010.02.10
-
Daiichi Sankyo to Launch Innovator Products in Mexico through Ranbaxy
Companies to Fully Leverage the Synergistic Power of the Hybrid Business Model
- 2010.02.08
- Announcement of Approval Application in Japan for Manufacturing and Marketing of SUN Y7017 (Memantine) for the Treatment of Alzheimer's Type Dementia
- 2010.02.03
- DAIICHI SANKYO INITIATES LARGEST SINGLE, DOUBLE-BLIND,RANDOMIZED, PHASE 3 TRIAL FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM
- 2010.02.01
- Daiichi Sankyo Submits a New Drug Application in Japan for CS-8958, a Long-Acting Neuraminidase Inhibitor for the Treatment of Influenza
- 2010.01.20
- Daiichi Sankyo Receives Approval to Manufacture and Market Rezaltas(R) Combination Tablets to Treat Hypertension
